Geode Capital Management, LLC Summit Therapeutics Inc. Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,934,815 shares of SMMT stock, worth $54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,934,815

Previous 3,284,882 10.66%

Holding current value

$54 Million

Previous $63.4 Million 1.44%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$16.64 - $36.7 $5.83 Million - $12.8 Million	-350,067 Reduced 10.66%	2,934,815 $62.5 Million
Q1 2025 May 13, 2025	BUY	$16.65 - $23.76 $1.4 Million - $2 Million	84,035 Added 2.63%	3,284,882 $63.4 Million
Q4 2024 Feb 12, 2025	BUY	$17.52 - $23.46 $1.77 Million - $2.37 Million	101,039 Added 3.26%	3,200,847 $57.1 Million
Q3 2024 Nov 12, 2024	BUY	$6.89 - $31.93 $936,909 - $4.34 Million	135,981 Added 4.59%	3,099,808 $67.9 Million
Q2 2024 Aug 09, 2024	SELL	$2.39 - $10.92 $450,665 - $2.06 Million	-188,563 Reduced 5.98%	2,963,827 $23.1 Million
Q1 2024 May 13, 2024	BUY	$2.55 - $5.07 $170,146 - $338,290	66,724 Added 2.16%	3,152,390 $13.1 Million
Q4 2023 Feb 13, 2024	BUY	$1.67 - $2.83 $214,767 - $363,946	128,603 Added 4.35%	3,085,666 $8.05 Million
Q3 2023 Nov 13, 2023	BUY	$1.54 - $2.42 $427,741 - $672,164	277,754 Added 10.37%	2,957,063 $5.53 Million
Q2 2023 Aug 11, 2023	BUY	$1.32 - $2.81 $2.1 Million - $4.47 Million	1,590,328 Added 146.04%	2,679,309 $6.73 Million
Q1 2023 May 15, 2023	BUY	$1.38 - $5.41 $851,885 - $3.34 Million	617,308 Added 130.88%	1,088,981 $1.91 Million
Q4 2022 Feb 13, 2023	BUY	$0.68 - $5.31 $100,219 - $782,593	147,381 Added 45.45%	471,673 $2 Million
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.63 $240,243 - $439,997	269,937 Added 496.62%	324,292 $385,000
Q2 2022 Aug 12, 2022	SELL	$0.92 - $2.38 $186,484 - $482,428	-202,701 Reduced 78.85%	54,355 $54,000
Q1 2022 May 13, 2022	BUY	$2.0 - $3.45 $16,470 - $28,410	8,235 Added 3.31%	257,056 $629,000
Q4 2021 Feb 11, 2022	SELL	$2.45 - $5.64 $6,529 - $15,030	-2,665 Reduced 1.06%	248,821 $669,000
Q3 2021 Nov 12, 2021	BUY	$4.83 - $8.27 $144,383 - $247,215	29,893 Added 13.49%	251,486 $1.26 Million
Q2 2021 Aug 13, 2021	BUY	$5.15 - $8.46 $908,346 - $1.49 Million	176,378 Added 390.09%	221,593 $1.65 Million
Q1 2021 May 12, 2021	BUY	$5.17 - $11.19 $133,406 - $288,746	25,804 Added 132.93%	45,215 $265,000
Q3 2020 Nov 13, 2020	BUY	$3.08 - $3.8 $59,785 - $73,761	19,411 New	19,411 $66,000

Others Institutions Holding SMMT

# of Institutions

259

Shares Held

90.4M

Call Options Held

4.71M

Put Options Held

3.17M

View Full List

About Summit Therapeutics Inc.

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.7B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

More about SMMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Summit Therapeutics Inc. Transaction History